Keyword: Rituxan

News

The Biosimilar Market

07.02.2014 - Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...

News

Roche Wins FDA Approval for Breakthrough Leukemia Drug

06.11.2013 - Swiss pharmaceutical giant Roche has received the green light from the U.S. Food and Drug Adminstration (FDA) to sell Gazyva (obinutuzumab), its new agent to treat chronic...

News

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

01.07.2013 - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...

News

Biogen Q2 Profit Up on MS Drug Sales

24.07.2012 - Biogen said on Tuesday its second-quarter earnings topped expectations on higher sales of its drugs to treat multiple sclerosis, and the company increased its profit forecast for...

Plant Construction & Process Technology

The World Of Biosimilars

30.05.2011 - Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...